E1071

PROGRESS IN THE STRUCTURE DETERMINATION OF A HUMAN TOPOISOMERASE I - DNA COMPLEX. Matthew R. Redinbo1, Lance Stewart1, Ehmke Pohl1, Xiayang Qiu1, James J. Champoux3, and Wim G. J. Hol1,2, 1Department of Biological Structure and 2Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, 3Department of Microbiology, University of Washington, Seattle, WA 98195

Progress in the structure determination of a complex of human topoisomerase I and double-stranded DNA will be described. Topoisomerases are a class of ubiquitous enzymes that control the level of DNA supercoiling in cells and are vital for transcription, translation and recombination. Topoisomerase I breaks a single strand of duplex DNA, forms a transient protein-DNA complex via a phosphotyrosine bond, and allows relaxation of superhelical strain about the intact DNA strand. Eukaryotic and prokaryotic topoisomerase I enzymes appear to be distinct and to have unique mechanistic characteristics. Human topoisomerase I is a 765 amino acid (91 kD) enzyme made up of four domains. Human topoisomerase I has been shown to be the sole target of the anti-cancer compound camptothecin and of camptothecin derivatives, and is thus of significant medical interest. Elevated levels of topoisomerase I have been identified in several human cancer cell types. We have obtained diffraction-quality crystals of a complex of a recombinantly expressed 70 kD portion of human topoisomerase I which includes the active site and double-stranded DNA. Data to 2.8 resolution has been collected at -170 C from native crystals and from crystals containing an iodinated DNA oligonucleotide. Structure determination is in progress using the multiple isomorphous replacement method.